mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.009 |
mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.009 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.01 |